Flagship Pioneering and Lean Business Services Company have announced a strategic collaboration to advance healthcare innovation and AI-enabled biomedical research in Saudi Arabia. The agreement was signed at the BIO International Convention 2026 in San Diego.
The partnership combines Lean’s national digital health infrastructure and health data capabilities with Flagship’s expertise in life sciences, artificial intelligence, and venture creation. Together, the organizations aim to accelerate scientific discovery, precision medicine, and healthcare innovation across the Kingdom.
Click here to join our WhatsApp channel here
Junaid Bajwa said, “We are in a new era in which AI and health data are fundamentally reshaping how we understand disease, discover medicines, and improve patient outcomes. Flagship has been at the forefront of applying AI across scientific research, platform innovation, and company creation, and we believe the combination of Lean’s exceptional data infrastructure and Saudi Arabia’s ambitious vision creates a uniquely powerful opportunity. Together, we can build an innovation ecosystem that accelerates discovery and delivers meaningful impact for patients in the Kingdom of Saudi Arabia and globally.”
During the first year, both parties will focus on evaluating priority initiatives, establishing governance frameworks, and identifying opportunities to strengthen Saudi Arabia’s life sciences ecosystem while ensuring compliance with privacy, security, and regulatory standards.
Also read: UAE Strengthens access to innovative care with New Fibrosis Drug Approval
Eng. Mohanned Alrasheed said, “Data and artificial intelligence are transforming how we understand disease, accelerate discovery, and improve patient outcomes. Saudi Arabia is uniquely positioned to lead this transformation through its investments in digital health, AI, and healthcare innovation.”
The collaboration supports Saudi Arabia’s Vision 2030 goals by advancing AI adoption in healthcare, enhancing research and development capabilities, attracting global expertise, and fostering a globally competitive life sciences sector.
